Discover Startup Events Near Me 

Allorion Therapeutics Completes $40M in Series A

Allorion Therapeutics Completes $40M in Series A Back to HomeNATICK, MA, Allorion Therapeutics, a company focused on oncology and autoimmune diseases, has completed a $40M Series A funding, led by Qiming Venture Partners. Allorion Therapeutics, a company focused on oncology and autoimmune diseases, announced the completion of $40M Series A financing. This financing round is led by Qiming Venture Partners and participated by IDG Capital, Octagon Capital, Firstred Capital, and Elikon Venture. Existing investors- TF Capital and Med-Fine Capital- continued to support in this round. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Startup Around is now on Telegram and Whatsapp. For the best startup stories & resources, subscribe us on Telegram & Whatsapp.
Ad